Rostil,250 mg, tablets
Calcii dobesilas monohydricus
This medicine should always be taken exactly as described in the package leaflet for the patient or as advised by a doctor or pharmacist.
Rostil is a medicine in the form of tablets. It contains the active substance calcium dobesilate monohydrate, which acts on the capillary endothelium, vein walls, and lymphatic vessels. The medicine reduces the permeability of capillaries, increases their resistance, preventing the formation of exudates and improving microcirculation.
The medicine increases the tension of the vein wall, preventing the formation of stasis and thrombi in the venous vessels. It enhances collagen synthesis, reduces blood plasma viscosity, and increases its flow through peripheral tissues.
It has a sealing effect on the vessels in the lymphatic system, causing a reduction in swelling, leading to the disappearance of painful symptoms and a feeling of heaviness in the limbs.
Treatment of symptoms of chronic venous insufficiency of the lower limbs (varicose veins): pain, cramps, tingling, swelling, skin changes due to blood stasis.
Before starting to take Rostil, the patient should discuss it with their doctor or pharmacist:
The patient should tell their doctor or pharmacist about all medicines they are taking or have recently taken, as well as any medicines they plan to take.
There is no data on the interaction of calcium dobesilate with other medicines.
The medicine should be taken during meals.
If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a child, they should consult their doctor or pharmacist before taking this medicine.
Pregnancy
The medicine should not be used during the first trimester of pregnancy.
The medicine may be used during pregnancy only if the doctor considers it absolutely necessary.
Breastfeeding
The medicine should not be used during breastfeeding.
The medicine does not affect the ability to drive or operate machines.
If the patient has previously been diagnosed with intolerance to some sugars, they should consult their doctor before taking the medicine.
The medicine contains 0.319 mg of sodium in each tablet.
The medicine contains less than 1 mmol (23 mg) of sodium per tablet, which means the medicine is considered "sodium-free".
This medicine should always be taken exactly as described in the package leaflet for the patient or as advised by a doctor or pharmacist. In case of doubt, the patient should consult their doctor or pharmacist.
The medicine is for oral use.
Adults: 500 mg (2 tablets) to 1000 mg (4 tablets) per day, i.e., 2 tablets 1-2 times a day.
The medicine should be taken during meals.
Treatment may last from several weeks to several months.
In case of taking more than the recommended dose of the medicine, the patient should immediately consult their doctor or pharmacist.
The patient should continue taking the medicine, without increasing the next dose.
A double dose should not be taken to make up for a missed dose.
In case of any further doubts about the use of this medicine, the patient should consult their doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Rare(occurring in 1 to 10 people out of 10,000):
Very Rare(occurring in less than 1 person out of 10,000):
These symptoms disappear after reducing the dose or discontinuing the medicine.
If any side effects occur, including any possible side effects not listed in this leaflet, the patient should inform their doctor or pharmacist.
Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products
Al. Jerozolimskie 181C, 02-222 Warsaw
Phone: +48 22 49 21 301
Fax: +48 22 49 21 309
website: https://smz.ezdrowie.gov.pl
Side effects can also be reported to the marketing authorization holder.
Reporting side effects will help gather more information on the safety of the medicine.
The medicine should be stored out of sight and reach of children.
Store in a temperature below 25°C.
Do not use this medicine after the expiry date stated on the blister and carton after EXP. The expiry date refers to the last day of the month.
Lot means batch number.
Medicines should not be disposed of via wastewater or household waste. The patient should ask their pharmacist how to dispose of medicines no longer required. This will help protect the environment.
The medicine is in the form of tablets.
The pack contains 30 or 60 tablets. The blisters are packed in a cardboard box with a leaflet.
Aflofarm Farmacja Polska Sp. z o.o.
ul. Partyzancka 133/151
95-200 Pabianice
phone: (42) 22-53-100
Aflofarm Farmacja Polska Sp. z o.o.
ul. Szkolna 31
95-054 Ksawerów
Date of Last Revision of the Leaflet:08.02.2021
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.